Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 January 2025 : Review article  

Skeletal Muscle Relaxants and Their Impact on Intracranial Pressure in Neurosurgery

Łukasz Grabarczyk ORCID logo1ABCDEFG, Huang Wen-Tau2ABCDEF, Małgorzata Rymsza2ABCDEF, Agnieszka Stankiewicz2ABCDEF, Marta Dobrzeniecka-Al Dhaif2ABCDEF, Maciej Szewczyk ORCID logo3ABCDEFG*

DOI: 10.12659/MSM.946569

Med Sci Monit 2025; 31:e946569

Table 1 Summary of main effects of different neuromuscular blocking agents (NBMA) of the revised clinical studies. Studies are assigned to specific NBMAs and presented in reverse chronological order. For each study, the first author, year of publication, number of patients studied, NMBA used, most relevant cerebrovascular effects, and corresponding reference are provided.

Drug groupNMBACerebrovascular effectsFirst Author, yearReferencePatients (n)Control group
Depolarizing agentSuccinylcholineICP does not changeKovarik, 1994[]20 10Same patient
ICP increasedStirt, 1987[]21 12Two groups
ICP increasedMinton, 1986[]19 13Same patient
BenzylisoquinolinesAtracuriumICP, CPP, CBFV, and MAP decreasedSchramm, 1998[]30 14Same patient
Control of otherwise unstable ICPMcClelland, 1995[]29 4Same patient
No changes in ICP, CPP, or MAPUnni, 1986[]27 9Same patient
No changes in ICP, MAP, CVP, HR, and etCO2Rosa, 1986[]26 25Same patient
No changes in ICP, CPP, or MAPMinton, 1985[]25 20Two groups
CisatracuriumPrevention of increase in ICPChivite Fernández, 2005[]48 13Same patient
No changes in ICP, CPP, CBFV, and MAPSchramm 1998[]30 14Same patient
No changes in ICP, CPP, CBFV, MAP, and HR regardless of doseSchramm, 1997[]31 24Two groups
MivacuriumNo changes in ICP, CSFP or MAPCafiero, 1999[]35 12Same patient
AminosteroidsPancuroniumICP decreased, elevated HR and arterial pressureThiel, 1996[]41 10Two groups
PipecuroniumICP decreased, stable HR and arterial pressureThiel, 1996[]41 10Two groups
No changes in ICP, MAP, CVP, HR, and etCO2Di Giugno, 1992[]49 10Same patient
RocuroniumNo significant changes in ICP, MAP, CPP. Treatment caused slight increase in HRSchramm, 1996[]47 20Two groups
VecuroniumICP increasedKerwin 2000[]50 23Same patient
Treatment caused no significant changes in ICP, CPP, or MAPSchramm, 1996[]47 20Two groups
ICP slightly decreasedRosa, 1986[]43 20Same patient
ICP – intracranial pressure; CPP – cerebral perfusion pressure; CBFV – cerebral blood flow velocity; MAP – mean arterial pressure; CVP – central venous pressure; HR – heart rate; etCO2 – end-tidal CO2; CSFP – cerebrospinal fluid pressure.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750